9[2]Smathers,RL,Bush E,Drace J,et al.Mammographic microcalcifications:detection with Xerography,screen-film,and digitized film display[J].Radiology,1986,159(3):673-677.
10[5]American College of Radiology(ACR). Mammography qanlity control manual[M]. Reston:American College of Radiology, 1999.9-78.
3Mandelson MT,Oestreicher N,Porter PL,et al.Breast density as a predictor of mammmographic detection:comparison of interval and screen detected cancers[J].Jnatl Cancer Inst,2000,92(13):1081-1087.
4Stern DF, Heffernan PA, Wenberg RA. p185, a product of the neu proto- oneogene,is a reeeptorlike protein associated with tyrosine kinase activity[J]. Mol Cell Biol, 1986,6 (5) : 1729-1740.
5Essapen S,Thomas H, Green M,et al. The expression and prognostic sig- nificance of HER-2 in eolorectal cancer and its relationship with elinieo- pathological parameters [J]. Int J Oncol, 2004,24 (2) : 241-248.
6Half E, Broaddus R, Danenberg KD, et al. HER-2 receptor expression, localization, and activation in colorectal cancer cell lines and human tu- mors [J]. Int J Cancer,2004,108(4) :540-548.
7Pohl M, Strieker I, Schoeneck A, et al. Antitumor activity of the HER2 dimerization inhibitor pertuzumab on human colon cancer cells in vitro and in vivo[J]. J Cancer Res Clin Onco1,2009,135 (10) : 1377-1386.
8Vogel CL, Cobleigh MA,Tripathy D, et al. Efficacy and safety of trastuzu- mab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer[J]. Clin Oncol, 2002,20 (3) : 719-726.
9Riemer AB, Klinger M,Wagner S, et al. Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/ neu[J]. J Immunol, 2004,173 ( I ) : 394-401.
10Marx AH, Burandt EC,Chosehzick M,et al. Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers[J]. Hum Pathol, 2010,41 ( 11 ) : 1577-1585.
